Search Results - "WALTON, Zandra"

Refine Results
  1. 1

    MYC, Metabolism, and Cancer by Stine, Zachary E, Walton, Zandra E, Altman, Brian J, Hsieh, Annie L, Dang, Chi V

    Published in Cancer discovery (01-10-2015)
    “…The MYC oncogene encodes a transcription factor, MYC, whose broad effects make its precise oncogenic role enigmatically elusive. The evidence to date suggests…”
    Get more information
    Journal Article
  2. 2
  3. 3

    ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation by Qing, Guoliang, Li, Bo, Vu, Annette, Skuli, Nicolas, Walton, Zandra E., Liu, Xueyuan, Mayes, Patrick A., Wise, David R., Thompson, Craig B., Maris, John M., Hogarty, Michael D., Simon, M. Celeste

    Published in Cancer cell (13-11-2012)
    “…Oncogenic Myc alters mitochondrial metabolism, making it dependent on exogenous glutamine (Gln) for cell survival. Accordingly, Gln deprivation selectively…”
    Get full text
    Journal Article
  4. 4

    Fructose-1,6-bisphosphatase opposes renal carcinoma progression by Li, Bo, Qiu, Bo, Lee, David S. M., Walton, Zandra E., Ochocki, Joshua D., Mathew, Lijoy K., Mancuso, Anthony, Gade, Terence P. F., Keith, Brian, Nissim, Itzhak, Simon, M. Celeste

    Published in Nature (London) (11-09-2014)
    “…Fructose-1,6-bisphosphatase is shown to be depleted in clear cell renal cell carcinoma (ccRCC) and inhibits ccRCC progression by antagonizing glycolytic flux…”
    Get full text
    Journal Article
  5. 5

    MYC and metabolism on the path to cancer by Hsieh, Annie L., Walton, Zandra E., Altman, Brian J., Stine, Zachary E., Dang, Chi V.

    Published in Seminars in cell & developmental biology (01-07-2015)
    “…•The MYC proto-oncogene is commonly deregulated and activated in human cancers.•MYC-dependent metabolism is critical for tumor growth.•MYC alters metabolism…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy by Walton, Zandra E, Frigault, Matthew J, Maus, Marcela V

    Published in Expert opinion on pharmacotherapy (11-02-2024)
    “…Chimeric antigen receptor (CAR) T cells have revolutionized the treatment of multiple hematologic malignancies. Engineered cellular therapies now offer similar…”
    Get more information
    Journal Article
  9. 9

    mTOR Senses Intracellular pH through Lysosome Dispersion from RHEB by Walton, Zandra E., Brooks, Rebekah C., Dang, Chi V.

    Published in BioEssays (01-07-2019)
    “…Acidity, generated in hypoxia or hypermetabolic states, perturbs homeostasis and is a feature of solid tumors. That acid peripherally disperses lysosomes is a…”
    Get full text
    Journal Article
  10. 10

    Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition by Johnson, Neil, Li, Yu-Chen, Walton, Zandra E, Cheng, Katherine A, Li, Danan, Rodig, Scott J, Moreau, Lisa A, Unitt, Christine, Bronson, Roderick T, Thomas, Huw D, Newell, David R, D'Andrea, Alan D, Curtin, Nicola J, Wong, Kwok-Kin, Shapiro, Geoffrey I

    Published in Nature medicine (01-07-2011)
    “…This report identifies Cdk1's phosphorylation of BRCA1 as an important regulator of BRCA1's DNA repair function. Cdk1 inhibition renders cancer cells sensitive…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Inflammatory cytokines in major depressive disorder: A case–control study by Cassano, Paolo, Bui, Eric, Rogers, Andrew H, Walton, Zandra E, Ross, Rachel, Zeng, Mary, Nadal-Vicens, Mireya, Mischoulon, David, Baker, Amanda W, Keshaviah, Aparna, Worthington, John, Hoge, Elizabeth A, Alpert, Jonathan, Fava, Maurizio, Wong, Kwok K, Simon, Naomi M

    “…Introduction: There is mixed evidence in the literature on the role of inflammation in major depressive disorder. Contradictory findings are attributed to lack…”
    Get full text
    Book Review Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Characterization of the cell of origin for small cell lung cancer by Park, Kwon-Sik, Liang, Mei-Chih, Raiser, David M., Zamponi, Raffaella, Roach, Rebecca R., Curtis, Stephen J., Walton, Zandra, Schaffer, Bethany E., Roake, Caitlin M., Zmoos, Anne-Flore, Kriegel, Christina, Wong, Kwok-Kin, Sage, Julien, Kim, Carla F.

    Published in Cell cycle (Georgetown, Tex.) (15-08-2011)
    “…Small cell lung carcinoma (SCLC) is a neuroendocrine subtype of lung cancer that affects more than 200,000 people worldwide every year with a very high…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Abstract 2669: Glutaminase alternative splicing controls tumor growth and metabolism by Stine, Zachary, Walton, Zandra E., Zhang, Lin, Fan, Teresa MW, Lane, Andrew N., Dang, Chi V.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Cancer cells reprogram their metabolism to meet their energetic and biosynthetic needs, with many cancer cells showing increased aerobic glycolysis…”
    Get full text
    Journal Article